PGP and chronic myelogenous leukemia, BCR-ABL1 positive: For instance, when combining ethyllucidenates A and vincristine in the treatment of CML cancer cell line K562/A02 that over-expressed P-gp, the percentage of G2/M arrest was significantly larger than the vincristine only group [25].